No immediate trading catalyst. Monitor for actual insider purchases via Form 4 filings, which could signal confidence. The ATM sale to affiliates at market price lacks a discount, reducing dilution urgency.
Price Chart
Executive Summary
Pulse Biosciences disclosed that its Board authorized TD Cowen to sell common stock to company affiliates under an existing ATM agreement with up to $59,976,196 in aggregate offering price. Separately, 72% owner Robert Duggan and CEO Paul LaViolette indicated they are likely to purchase shares in the near term at prevailing market prices, but have not made binding commitments. This is a routine administrative update with no material financial impact.
Key Facts
- Board approved affiliate purchases under existing ATM agreement with TD Cowen for up to $59,976,196
- Robert Duggan (72% owner) and CEO Paul LaViolette indicated they are likely to buy shares but made no binding commitment
- No change to business operations, financial results, or guidance
Financial Impact
Up to $59.98 million potential equity issuance to affiliates, but no actual transactions disclosed
Risk Factors
- Potential dilution if affiliates sell shares into the ATM, though any sales would be at market price
- Lack of binding commitments means insider buying may not materialize
Market Snapshot
Investment Themes
Documents Analyzed
This report is based on 4 SEC documents filed with EDGAR.
| Document | Accession Number |
|---|---|
| 8-K Filing (Primary) | 0001437749-26-015039 |
| Document: 0001437749-26-015039-index-headers.html | 0001437749-26-015039 |
| Document: 0001437749-26-015039-index.html | 0001437749-26-015039 |
| Document: 0001437749-26-015039.txt | 0001437749-26-015039 |
Filters
| Type | Now | ||||
|---|---|---|---|---|---|
Oct 14, 2026 12d ago | 8-K | $46.32 | awaiting T+60 | — | $52.66 (+13.69%) |
Oct 7, 2026 19d ago | 8-K | $49.09 | awaiting T+60 | — | $52.66 (+7.27%) |
Sep 15, 2026 5w ago | 8-K | $55.20 | awaiting T+60 | — | $52.66 (−4.60%) |
Aug 6, 2026 11w ago | 8-K | $42.41 | awaiting T+60 | — | $52.66 (−24.17%) |
Aug 6, 2026 11w ago | 424B5 | $42.41 | awaiting T+60 | — | $52.66 (−24.17%) |
Jul 29, 2026 12w ago | 8-K | $34.25 $52.68 | ▲ +53.81% | ▲ +49.08% | $52.66 (+53.75%) |
Jun 12, 2026 19w ago | Institutional Cluster | $24.37 $48.79 | ▲ +100.21% | ▲ +96.94% | $52.66 (+116.09%) |
Jun 10, 2026 19w ago | 8-K | $24.99 $54.71 | ▲ +118.93% | ▲ +112.35% | $52.66 (+110.72%) |
May 15, 2026 23w ago | Insider Cluster | $25.61 $43.32 | ▲ +69.15% | ▲ +64.30% | $52.66 (+105.62%) |
May 11, 2026 24w ago | Insider Cluster | $19.08 $37.90 | ▲ +98.64% | ▲ +94.24% | $52.66 (+176.00%) |
US Market Status
Subscribe to SecBot
Get Real-Time SEC Filing Intelligence
Comprehensive SEC filing analysis delivered the moment filings hit EDGAR. Sentiment scoring, impact analysis, and actionable insights for every material event.
Create a free account Live analysis, Telegram alerts, watchlists and the MCP server for subscribers